by Combat Cancer | Jan 19, 2024 | News
Bladder cancer is among the most common types of cancer, with varying degrees of invasiveness. Non-muscle-invasive bladder cancer (NMIBC) is a subtype where cancer cells are confined to the surface layers of the bladder wall and have not invaded the muscle layer. This...
by Combat Cancer | Jan 11, 2024 | News
Shaping the Future of Bladder Cancer Care Hosted by MEP Isátv Ujhelyi, a momentous policy roundtable was convened on 25 September 2023, where the white paper’s recommendations were unveiled. The discussion was centred around identifying legislative opportunities...
by Combat Cancer | Dec 21, 2023 | News
Combat’s Guy Cooper is in conversation with Dr Lana Bijelic, chief of the Peritoneal Surface Malignancy Unit at the Hospital Sant Joan Despí Moisès Broggi Hospital, Barcelona. Dr Bijelic is a surgical oncologist and a specialist in peritoneal carcinomatosis. She...
by Combat Cancer | Dec 14, 2023 | News
Higher intakes of dietary folate – vitamin B9, found mainly in leafy greens such as cabbage or broccoli, wholegrains, pulses and citrus fruit – or folic acid supplements could help decrease the risk of colorectal cancer, according to a new study just published in the...
by Combat Cancer | Dec 7, 2023 | News
In healthcare, few challenges are as complex and multifaceted as cancer diagnosis. However, the arrival of artificial intelligence (AI) is heralding a new era in cancer care, promising greater accuracy, speed, and personalisation. Welcome to the future of medicine....
by Combat Cancer | Nov 29, 2023 | News
Did you know that AI can detect hidden, potentially curable pancreatic cancers? Pancreatic ductal adenocarcinoma (PDA) is the third leading cause of cancer-related deaths in the US and the fifth biggest in the UK. Earlier detection has been shown to improve surgical...
Recent Comments